Financial PerformanceSYK's revenue in 3Q comfortably beat Street expectations, with notable performances in various business units.
Market LeadershipStryker enjoys market-leading positions in the $41B orthopedic market, the $31B MedSurg, and the $8B neurovascular market.
Product LaunchesSYK's ongoing super cycle of key product launches across the portfolio is anticipated to be a material tailwind for the company through at least the remainder of 2024 and 2025.